unknown
Stage
About
Anagin develops novel targeted therapies addressing synaptic plasticity disruptions in the central nervous system to treat neuropsychiatric disorders such as PTSD, depression, neuropathic pain, Alzheimer's, and Parkinson's disease.
Explore Anagin's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.